GALWAY, IRELAND--November 23, 2020--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--The European Commission (EC) has signed a deal for up to 300 million doses of BioNTech-Pfizer's COVID-19 vaccine just weeks after the partners' claimed that early test results found it to be more than 90% effective. Within this article: Details deal for COVID-19 potential vaccine, partners involved, manufacturing plants, capacities and timelines
(All Fields Required)
Site-wide Scheduled Maintenance for April 12, 2025, between 9 A.M. - 9 P.M. CST. During this time, all services will be unavailable periodically throughout the scheduled maintenance window.
×For More Info!
